Home Apnea Testing in CHildren Trial

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · May 16, 2022

Keywords

ClinConnect Summary

The Home Apnea Testing in Children Trial is a study designed to compare two methods of testing for sleep apnea in children: a home test and a traditional sleep study done in a lab. The goal is to see how accurate each method is, how well they help doctors make treatment decisions, and how acceptable they are for both children and their parents. This is important because sleep apnea can affect a child's health and well-being, and finding the best way to diagnose it is crucial.

To participate in this trial, children must be between the ages of 5 and 12 and have been referred for a sleep study at the Children’s Hospital of Philadelphia. Parents or guardians will need to give permission for their child to join the study, and if applicable, the child will also need to agree. However, children who have had a sleep study in the last three years or have certain medical conditions, like needing extra help to breathe during sleep, cannot participate. If enrolled, families can expect to learn more about their child's sleep health and the best ways to manage any sleep-related issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male and female children age 5-12 years old inclusive
• • Referred for diagnostic PSG at the Children's Hospital of Philadelphia (CHOP) Sleep Laboratory for evaluation of OSA as part of clinical care
• • Parental/guardian permission (informed consent) and if appropriate, child assent.
• Exclusion Criteria:
• • Children without Down syndrome who have had a PSG within 3 years of enrollment
• • Children with Down syndrome who have had a PSG within 1 year of enrollment.
• • Children with a history of hypoventilation or hypoxemia or who require supplemental oxygen or positive airway pressure during sleep
• • Children with a tracheostomy or tracheocutaneous fistula
• • Children who live in a facility without their parent